Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks536565-BOM
resources
536565-BOM

Novelix Pharmaceuticals Ltd.

BSE: 536565
Industry Group: Retailing
Industry: Pharmacy Retail
60.99-1.8 (-2.79%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Novelix Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results————————————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Novelix Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.
  2. Change in Directorate2 Oct 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Attached
  3. AGM1 Oct 2026
    Shareholders Meeting- Voting Results
    Attached
  4. AGM1 Oct 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Submission of Voting results & Scrutinizers Report.
  5. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Submission of Outcome of the 32nd Annual General Meeting.
  6. Closure of Trading Window30 Sept 2026
    Closure of Trading Window
    Attached
  7. Newspaper Publication9 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of Newspaper Publication.
  8. General7 Sept 2026
    Announcement Under Regulation 30 (LODR)- Letter Of Annual Report & AGM Notice Weblink
    Attached.
  9. AGM7 Sept 2026
    Shareholders Meeting- Notice Of Annual General Meeting To Be Held On Wednesday, 30Th September, 2026.
    Attached.
  10. Reg. 34 (1) Annual Report7 Sept 2026
    Reg. 34 (1) Annual Report.
    Submission of annual report for the financial year ended March 31, 2026.
  11. AGM31 Aug 2026
    Shareholders Meeting AGM On 30Th September, 2026.
    Submission of Intimation of AGM Date.
  12. Change in Directorate31 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Submission of intimation of change in Designation of Director.
  13. Outcome of Board Meeting29 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026
    Submission of outcome of the board meeting.
  14. Board Meeting25 Aug 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026
    Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 ,inter alia, to consider and approve Submission of Prior ....
  15. General20 Aug 2026
    Announcement Under Regulation 30 (LODR) - Lease Deed
    Submission of Intimation of Land Lease Deed.
  16. Newspaper Publication16 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submission of Newspaper Publication of the financial results for the quarter ended 30th June, 2026.
  17. Reg. 32 (1), (3) - Statement of Deviation & Variation13 Aug 2026
    Compliances- Statement Of Deviation & Variation
    Submission of Statement of Deviation & Variation
  18. Outcome of Board Meeting13 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Submission of outcome of the Board meeting.
  19. Board Meeting9 Aug 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 13Th August, 2026.
    Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior ....
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201816 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Frequently Asked Questions

Where can I download the annual report of Novelix Pharmaceuticals Ltd.?
Annual reports of Novelix Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Novelix Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Novelix Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Novelix Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Novelix Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Novelix Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Novelix Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Novelix Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Novelix Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Novelix Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Novelix Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Novelix Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Novelix Pharmaceuticals Ltd. is INE314I01036. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Novelix Pharmaceuticals Ltd. listed?
Novelix Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 536565-BOM and the BSE code is -.
Where can I find the shareholding pattern of Novelix Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Novelix Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Novelix Pharmaceuticals Ltd. on Sharpely?
Share price data for Novelix Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.